Beranda › Tumor Otak
Uji klinis Tumor Otak yang merekrut di AS
198 studi untuk Tumor Otak merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX35 studi
- Boston, MA28 studi
- New York City, NY25 studi
- Washington, DC20 studi
- Los Angeles, CA16 studi
- Miami, FL15 studi
- Durham, NC14 studi
- St. Louis, MO12 studi
- Rochester, MN12 studi
- Cleveland, OH11 studi
- Columbus, OH11 studi
- Baltimore, MD11 studi
- Chicago, IL11 studi
- Seattle, WA11 studi
- Ann Arbor, MI10 studi
- Aurora, CO9 studi
- Atlanta, GA9 studi
- Detroit, MI9 studi
- Arlington, VA8 studi
- Nashville, TN8 studi
- Portland, OR8 studi
- Minneapolis, MN8 studi
- Dallas, TX8 studi
- San Francisco, CA8 studi
- San Antonio, TX7 studi
- Jacksonville, FL7 studi
- Baldwin Park, CA7 studi
- San Diego, CA7 studi
- Mountain View, CA7 studi
- Cincinnati, OH7 studi
- Salt Lake City, UT7 studi
- Philadelphia, PA7 studi
- Tampa, FL6 studi
- Birmingham, AL5 studi
- Madison, WI5 studi
- Milwaukee, WI5 studi
- Winston-Salem, NC5 studi
- Scottsdale, AZ5 studi
- New Rochelle, NY4 studi
- Edison, NJ4 studi
Berdasarkan negara bagian
- Alabama5 studi
- Arizona11 studi
- Arkansas3 studi
- California39 studi
- Colorado11 studi
- Distrik Columbia13 studi
- Florida29 studi
- Georgia12 studi
- Idaho3 studi
- Illinois14 studi
- Indiana4 studi
- Iowa4 studi
- Kansas3 studi
- Kentucky5 studi
- Maryland18 studi
- Massachusetts29 studi
- Michigan19 studi
- Minnesota19 studi
- Missouri13 studi
- Montana3 studi
- Nebraska5 studi
- New Hampshire4 studi
- New Jersey8 studi
- New York35 studi
- North Carolina20 studi
- Ohio23 studi
- Oklahoma3 studi
- Oregon8 studi
- Pennsylvania13 studi
- Rhode Island3 studi
- South Carolina5 studi
- Tennessee12 studi
- Texas42 studi
- Utah8 studi
- Virginia15 studi
- Washington12 studi
- Wisconsin11 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05222620GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Menerima pesertaFase 1
Usia 21 hingga 70 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06815432Evaluation and Treatment of Neurosurgical Disorders
Menerima pesertaStudi observasional
Usia 4 hingga 99 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT00060541Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
Menerima pesertaFase 1/2
6 Months – 25 Years · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT04085887Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07326566SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT04923542Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Menerima pesertaFase 1/2
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07416188C-SMART vs BE Well for Patients With Brain Tumors
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07224503Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06047379Extracellular Impact of Ultrasound-induced Blood-brain Barrier Disruption
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT05733312RNA-Lipid Particle (RNA-LP) Vaccines for Recurrent Adult Glioblastoma (GBM)
Menerima pesertaFase 1
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06389591Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07248228Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07470606REMIND Maintenance Radiotherapy for Newly Diagnosed Glioblastoma
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07831772Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT04977375Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis
Menerima pesertaFase awal 1
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06055790PilotStudyAssessSafeActiveSurveillancApproachLocalThe Pa w/BrainMetsUndergoinCNSPenetratSystemicThe
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07827001Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07053033Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07227610A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05048212A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07492680Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT05786924A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT04511013Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Menerima pesertaFase 2
59 Months · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT05535166OBSERVE: A Pilot Study Of Omission Of Brain Metastasis Stereotactic Radiosurgery Following Resection With CNS-Active Systemic Therapy
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07655583Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.